WHITE PLAINS, N.Y., April 5, 2013 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is committed to bringing the most current information about blood cancers to all patients and is pleased to announce a unique educational opportunity for Spanish-speaking patients with chronic myeloid leukemia (CML). On Wednesday, April 17, from 1:00 to 2:00 PM Eastern Time, international CML expert Dr. Jorge Cortes from The University of Texas MD Anderson Cancer Center will present a free, live telephone/web education program titled CML–Living with a Chronic Disease. This program will be presented simultaneously in Spanish.
Since the advent of targeted therapies, three of which are now approved for the treatment of newly diagnosed chronic phase CML, survival and quality of life for patients with CML has dramatically improved. Recent studies show that more than 90% of newly diagnosed, early stage CML patients can expect to survive long-term. Just as LLS was instrumental in funding the research which led to the development of imatinib (Gleevec ®), LLS is also committed to ensuring that these treatment advances reach all patients. The telephone/web program on April 17 will provide Spanish-speaking patients and caregivers the opportunity to learn about the latest advances in CML treatment and quality of life from one of the leading experts in the field. Dr. Cortes will discuss CML treatment options, as well as the critical importance of treatment adherence and monitoring of treatment response. This program, offered by The Leukemia & Lymphoma Society in collaboration with Abrale and Alianza Latina is supported by grants from Bristol-Myers Squibb and Novartis Oncology. The Leukemia & Lymphoma Society is pleased to offer continuing education credit for nurses and social workers.
To register for the April 17 program CML–Living with a Chronic Disease in Spanish, please visit www.LLS.org/CMLsp.
To register for CML–Living with a Chronic Disease in English, please visit www.LLS.org/programs.For information on other LLS programs, please visit www.LLS.org or contact an Information Specialist at (800) 955-4572. About The Leukemia & Lymphoma SocietyThe Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. Contact: Andrea Greif914.821.8958 email@example.com SOURCE The Leukemia & Lymphoma Society